Form 4: Vaxcyte Executive Reports Stock Transaction
Insider Transaction (Form 4)
Elvia Cowan, SVP, Finance & CAO of Vaxcyte, Inc., reported multiple transactions in common stock on August 31, 2026.
Summary
- Tax/exercise-price withholding: disposed of 243 Common Stock at $60.74 ($14,760) on August 31, 2026; holds 29,513 after (Direct).
- Tax/exercise-price withholding: disposed of 326 Common Stock at $61.58 ($20,075) on September 2, 2026; holds 29,187 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Elvia Cowan — Officer (SVP, Finance & CAO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Tax/exercise-price withholding | Common Stock | 243 | $61 | $14.8K | 29,513 |
| 2026-09-02 | Tax/exercise-price withholding | Common Stock | 326 | $62 | $20.1K | 29,187 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Tax/exercise-price withholding (243 shares) |
| 2026-09-02 | Tax/exercise-price withholding (326 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., neutral, Elvia Cowan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.